PCAS and All NOVACAP Subsidiaries Unify to Become SEQENS

Press Release | Longjumeau, France, January 14th 2019

SEQENS. A new name for a global leader in specialty ingredients and pharmaceutical synthesis.

PCAS and all NOVACAP subsidiaries unify their names into a new one and become SEQENS.

SEQENS is an integrated global leader in specialty ingredients and pharmaceutical synthesis, delivering unrivalled market responsiveness and tailor-made solutions to our customers. Read More

Archives